Business:
Biologics
Drug notes:
RZ402 Clin2 diabetic macular edema
About:
Rezolute is developing drug therapies to cure patients with metabolic diseases associated with chronic glucose imbalance. Both extreme low (hypoglycaemia) and high (hyperglycaemia) blood glucose levels cause disease. Rezolute is developing antibody-based therapies to treat patients with congenital hyperinsulinism (HI), diabetic macular edema and tumor HI. Their approach is to leverage their metabolic expertise to define disease pathways and create therapies that overcome the shortcomings of current standards of care. Rezolute’s lead program, RZ358, is in late-stage clinical trials for congenital HI.
Senior Manager, Manufacturing Operations Redwood City Bend|6 days ago
Vice President, Commercial Operations Redwood City|10 days ago
Vice President, Marketing Redwood City|11 days ago
Senior Director, Value, Pricing & Reimbursemen... Redwood City Remote|29 days ago
Office Operations Manager Redwood City|31 days ago
Director, Legal – Clinical & Commercial Contra... Redwood City|51 days ago
Associate Director -Corporate Communications Redwood City|52 days ago
Chief Commercial Officer Redwood City|60 days ago
Associate Director - Patient Affairs Redwood City|100 days ago